BANK VONTOBEL/CALL/ROCHE GS/320/0.02/19.12.25 Share Price

Warrant

WROA9V

CH1312986511

Real-time Bid/Ask 07:00:23 03/07/2024 pm IST
0.1 CHF / 0.11 CHF -7.89% Intraday chart for BANK VONTOBEL/CALL/ROCHE GS/320/0.02/19.12.25
Current month-6.56%
1 month+42.50%
Date Price Change
02/24/02 0.114 -1.72%
01/24/01 0.116 -4.92%
28/24/28 0.122 -4.69%
26/24/26 0.128 -5.88%

Delayed Quote Swiss Exchange

Last update July 02, 2024 at 08:50 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WROA9V
ISINCH1312986511
Date issued 09/01/2024
Strike 320 CHF
Maturity 19/12/2025 (534 Days)
Parity 50 : 1
Emission price 0.1 CHF
Emission volume N/A
Settlement physical
Currency CHF

Technical Indicators

Highest since issue 0.136 CHF
Lowest since issue 0.058 CHF
Spread 0.01 CHF
Spread %9.09%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
248.5 CHF
Average target price
278.3 CHF
Spread / Average Target
+11.98%
Consensus
  1. Stock Market
  2. Warrants
  3. WROA9V Warrant